Intervention in acute cerebral ischaemic stroke: A review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices

Postgraduate Medical Journal

Volumn 87, Issue 1032, 2011, Pages 714-723

  Chaudhary, Neeraj ^a   Pandey, Aditya S ^a   Gemmete, Joseph J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; DESMOTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; PLACEBO; PROUROKINASE; TENECTEPLASE; UROKINASE;

ACUTE ISCHEMIC STROKE; BRAIN ISCHEMIA; DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; IMAGING; INTRAARTERIAL MECHANICAL THROMBECTOMY DEVICE; PERCUTANEOUS THROMBECTOMY; RECANALIZATION; REHABILITATION CARE; REVASCULARIZATION; REVIEW; STENT; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; PATIENT SELECTION; STENTS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY;

EID: 80053378344     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2010.105171     Document Type: Review

References (50)

1. National Collaborating Centre for Chronic Conditions. Stroke: National Clinical guidelines for Diagnosis and the Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). London: Royal College of Physicians, 2008.
2. Novakovic R, Toth G, Purdy PD. Review of current and emerging therapies in acute ischemic stroke. J Neurointerv Surg 2009;1:1-26.
3. Warren DJ, Musson R, Connolly DJA, et al. Imaging in Acute Ischemic Stroke: Essential for Modern Stroke Care. Postgrad Med J 2010;86:40-18.
4. Lloyd-Jones D, Adams R, Carnethon M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:48-6.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:158-7.
6. Bluhmki E, Chamorro A, Davalos A, et al. Stroke treatment with alteplase given 3.-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 2009;8:109-102.
7. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association; on behalf of the American Heart Association Stroke Council. Stroke 2009;40:294-8.
8. National Clinical Stroke Guidelines UK. 2nd edn. UK: A publication from the Royal College of Physicians, 2008. http://www.rcplondon.ac.uk/.
9. Anon. Emergency and Comprehensive Care for Stroke needed. Editorial The Lancet 2009;373:1496.
10. European Stroke Organization (ESO). Guidelines for Stroke Therapy Document. Publication from European Stroke Organization, 2009. http://www.eso-stroke.org/.
11. Meyers PM, Schumacher CH, Higashida RT, et al; American Heart Association. Indications for the Performance of Intracranial Endovascular Neurointerventional Procedures; A Scientific Statement From the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:223-49.
12. Hacke W, Kaste M, Bluhmki E, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:131-29.
13. Hirsch JA, Yoo AJ, Nogueira RG, et al. Case volumes of intra-arterial and intravenous treatment of ischemic strokes in the USA. J Neurointerv Surg 2009;1:2-31.
14. Hacke W, Albers G, Al-Rawi Y, et al; DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:6-73.
15. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:122-31.
16. Adams HP Jr, Effron MB, Torner J, et al; AbESTT-II Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:8-99.
17. Torgano G, Zecca B, Monzani V, et al. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. Cerebrovasc Dis 2010;29:27-81.
18. del Zoppo GJ, Higashida RT, Furlan AJ, et al; PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:11.
19. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:200-11.
20. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:259-605.
21. The IMS Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004;35:90-12.
22. The IMS II trial investigators. The interventional management of stroke (IMS) II study. Stroke 2007;38:212-35.
23. Khatri P, Hill MD, Palesch YY, et al; For the IMS III investigators. Methodology of the Interventional Management of Stroke III trial. Int J Stroke 2008;3:13-7.
24. Hill MD, Barber PA, Demchuk AM, et al. Acute intravenouseintra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002;33:27-82.
25. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:8-4.
26. Suarez JI, Zaidat OO, Sunshine JL, et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002;50:25-9; discussion 25-60.
27. Lee KY, Han SW, Kim SH, et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007;38:19-3.
28. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real world experience and a call for action. Stroke 2010;41:225-8.
29. Smith WS, Sung G, Starkman S, et al; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:143-8.
30. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemicstroke: final results of the Multi MERCI trial. Stroke 2008;39:120-12.
31. Bose A, Henkes H, Alfke K, et al; Penumbra Phase 1 Stroke Trial Investigators. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:140-13.
32. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:276-8.
33. Grunwald IQ, Walter S, Papanagiotou P, et al. Revascularization in acute ischaemic stroke using the penumbra system: the first single center experience. Eur J Neurol 2009;16:121-16.
34. Kulcsar Z, Bonvin C, Pereira VM, et al. Penumbra system: a novel mechanical thrombectomy device for large-vessel occlusions in acute stroke. AJNR Am J Neuroradiol 2010;31:62-33.
35. Struffert T, Kohrmann M, Engelhorn T, et al. Penumbra Stroke System as an "addon" for the treatment of large vessel occlusive disease following thrombolysis: first results. Eur Radiol 2009;19:228-93.
36. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intra-arterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:181-22.
37. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:128-8; discussion 128-90.
38. Berkenfeld C, Schroth G, Mattle HP, et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009;40:84-52.
39. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:284-54.
40. Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003;24:53-8.
41. Levy EI, Mehta R, Gupta R, et al. Self expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:81-22.
42. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:355-6.
43. Castano C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:183-40.
44. Mocco J, Hanel RA, Sharma J, et al. Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. J Neurosurg 2010;112:55-62.
45. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:310-9.
46. Alberts MJ, Latchaw RE, Selman WR, et al; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. javascript: AL_get (this,'jour','Stroke.'). Stroke 2005;36:159-616.
47. Perez de la Ossa N, Millan M, Arenillas JF, et al. Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis. J Neurol 2009;256:127-6.
48. Govan L, Weir CJ, Langhorne P, et al; For the stroke Unit Trialists' Collaboration. Organized inpatient (stroke unit) care for stroke. Stroke 2008;39:240-3.
49. Tateshima S, Zauner A, Barr J, et al. A Novel Microcatheter Based Device for Endovascular Mechanical Thrombectomy/Flow Restoration. J Neurointerv Surg 2010;2(Suppl 1):A3.
50. Machi P, Costalat V, Riquelme C, et al. Solitaire FR Stent used as a Revascularization device in Acute Ischemic Stroke. Acute Results: Montepellier preliminary experience. J Neurointerv Surg 2010;2(Suppl 1):A2.